The Role of Physiologically Based Oral Absorption Modelling in Formulation Development Under a Quality by Design Paradigm
- 1 April 2017
- journal article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 106 (4) , 944-949
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Optimizing Clinical Drug Product Performance: Applying Biopharmaceutics Risk Assessment Roadmap (BioRAM) and the BioRAM Scoring GridJournal of Pharmaceutical Sciences, 2016
- Physiologically Based Absorption Modeling to Impact Biopharmaceutics and Formulation Strategies in Drug Development—Industry Case StudiesJournal of Pharmaceutical Sciences, 2016
- Justification of Drug Product Dissolution Rate and Drug Substance Particle Size Specifications Based on Absorption PBPK Modeling for Lesinurad Immediate Release TabletsMolecular Pharmaceutics, 2016
- Application of Absorption Modeling in Rational Design of Drug Product Under Quality-by-Design ParadigmThe AAPS Journal, 2015
- The Biopharmaceutics Risk Assessment Roadmap for Optimizing Clinical Drug Product PerformanceJournal of Pharmaceutical Sciences, 2014
- PBPK models for the prediction of in vivo performance of oral dosage formsEuropean Journal of Pharmaceutical Sciences, 2014
- Understanding Pharmaceutical Quality by DesignThe AAPS Journal, 2014
- Survey Results for In Vitro-In Vivo Correlations (IVIVC): Critical Variables for SuccessDissolution Technologies, 2013
- The role of predictive biopharmaceutical modeling and simulation in drug development and regulatory evaluationInternational Journal of Pharmaceutics, 2011
- Utility of Physiologically Based Absorption Modeling in Implementing Quality by Design in Drug DevelopmentThe AAPS Journal, 2011